Search Results - "Juan P Casas"

Refine Results
  1. 1
  2. 2

    Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans by Dickerman, Barbra A, Gerlovin, Hanna, Madenci, Arin L, Kurgansky, Katherine E, Ferolito, Brian R, Figueroa Muñiz, Michael J, Gagnon, David R, Gaziano, J. Michael, Cho, Kelly, Casas, Juan P, Hernán, Miguel A

    Published in The New England journal of medicine (13-01-2022)
    “…In an observational study involving nearly 440,000 veterans, both the BNT162b2 vaccine and the mRNA-1273 vaccine were highly effective at preventing infection,…”
    Get full text
    Journal Article
  3. 3

    The druggable genome and support for target identification and validation in drug development by Finan, Chris, Gaulton, Anna, Kruger, Felix A, Lumbers, R Thomas, Shah, Tina, Engmann, Jorgen, Galver, Luana, Kelley, Ryan, Karlsson, Anneli, Santos, Rita, Overington, John P, Hingorani, Aroon D, Casas, Juan P

    Published in Science translational medicine (29-03-2017)
    “…Target identification (determining the correct drug targets for a disease) and target validation (demonstrating an effect of target perturbation on disease…”
    Get more information
    Journal Article
  4. 4

    Selecting instruments for Mendelian randomization in the wake of genome-wide association studies by Swerdlow, Daniel I, Kuchenbaecker, Karoline B, Shah, Sonia, Sofat, Reecha, Holmes, Michael V, White, Jon, Mindell, Jennifer S, Kivimaki, Mika, Brunner, Eric J, Whittaker, John C, Casas, Juan P, Hingorani, Aroon D

    Published in International journal of epidemiology (01-10-2016)
    “…Mendelian randomization (MR) studies typically assess the pathogenic relevance of environmental exposures or disease biomarkers, using genetic variants that…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Tackling non-communicable diseases in low- and middle-income countries: is the evidence from high-income countries all we need? by Ebrahim, Shah, Pearce, Neil, Smeeth, Liam, Casas, Juan P, Jaffar, Shabbar, Piot, Peter

    Published in PLoS medicine (01-01-2013)
    “…Shah Ebrahim and colleagues argue that more research on non-communicable diseases (NCDs) in both high-income countries and low- and middle-income countries can…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis by Casas, Juan P, Chua, Weiliang, Loukogeorgakis, Stavros, Vallance, Patrick, Smeeth, Liam, Hingorani, Aroon D, MacAllister, Raymond J

    Published in The Lancet (British edition) (10-12-2005)
    “…A consensus has emerged that angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-II receptor blockers (ARBs) have specific renoprotective effects…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Visualizing novel connections and genetic similarities across diseases using a network-medicine based approach by Ferolito, Brian, do Valle, Italo Faria, Gerlovin, Hanna, Costa, Lauren, Casas, Juan P., Gaziano, J. Michael, Gagnon, David R., Begoli, Edmon, Barabási, Albert-László, Cho, Kelly

    Published in Scientific reports (01-09-2022)
    “…Understanding the genetic relationships between human disorders could lead to better treatment and prevention strategies, especially for individuals with…”
    Get full text
    Journal Article
  12. 12

    Uric acid and risk of pre-eclampsia: results from a large case–control study and meta-analysis of prospective studies by Colmenares-Mejia, Claudia C., Quintero-Lesmes, Doris C., Bautista-Niño, Paula K., Guío, Elizabeth, Paez, Maria C., Beltrán, Mónica, Williams, David, Gray, Kathryn J., Casas, Juan P., Serrano, Norma C.

    Published in Scientific reports (21-02-2023)
    “…To quantify the association between maternal uric acid levels and pre-eclampsia risk in a large collection of primigravid women. A case–control study (1365…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Circulating Apolipoprotein E Concentration and Cardiovascular Disease Risk: Meta-analysis of Results from Three Studies by Sofat, Reecha, Cooper, Jackie A, Kumari, Meena, Casas, Juan P, Mitchell, Jacqueline P, Acharya, Jayshree, Thom, Simon, Hughes, Alun D, Humphries, Steve E, Hingorani, Aroon D

    Published in PLoS medicine (18-10-2016)
    “…The association of APOE genotype with circulating apolipoprotein E (ApoE) concentration and cardiovascular disease (CVD) risk is well established. However, the…”
    Get full text
    Journal Article
  17. 17

    Atrial fibrillation epidemiology, disparity and healthcare contacts: a population-wide study of 5.6 million individuals by Chung, Sheng-Chia, Sofat, Reecha, Acosta-Mena, Dionisio, Taylor, Julie A, Lambiase, Pier D, Casas, Juan P, Providencia, Rui

    Published in The Lancet regional health. Europe (01-08-2021)
    “…Background: We aimed to evaluate atrial fibrillation occurrence, reasons for healthcare visits, mortality, causes of death and examined patterns by relative…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Million Veteran Program's response to COVID-19: Survey development and preliminary findings by Whitbourne, Stacey B, Nguyen, Xuan-Mai T, Song, Rebecca J, Lord, Emily, Lyden, Michelle, Harrington, Kelly M, Ward, Rachel, Li, Yanping, Brewer, Jessica V V, Cho, Kelly M, Djousse, Luc, Muralidhar, Sumitra, Tsao, Philip S, Gaziano, J Michael, Casas, Juan P

    Published in PloS one (25-04-2022)
    “…In response to the novel Coronavirus Disease 2019 (COVID-19) pandemic, the Department of Veterans Affairs (VA) Million Veteran Program (MVP) organized efforts…”
    Get full text
    Journal Article
  20. 20